Chargement en cours...
Subcutaneous apomorphine in the treatment of Parkinson's disease.
Apomorphine a dopamine receptor agonist was given subcutaneously to 57 levodopa treated parkinsonian patients with refractory off-period disabilities for a median period of 16 months. In 30 given intermittent suprathreshold injections the mean number of hours spent in a disabling off state fell from...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1990
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC487943/ https://ncbi.nlm.nih.gov/pubmed/2313313 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|